The government of India's Institutional Ethical Committee has given the nod for a Unani medicine aimed at treating diabetes and its clinical trial will begin soon, said an Aligarh Muslim University professor who developed the drug.
Professor Naeem Ahmad Khan of the Department of Ilmul Advia, Ajmal Khan Tibbiya College of the AMU, said the medicine will cure diabetes by restoring the primary functions of beta islet cells to store and release insulin.
Khan said the medicine had already been successfully tested on animals.
He said the drug was developed from eight medicinal plants and will be extremely affordable.
He said Professor Imrana Naseem of the university's Biochemistry Department contributed to the research that led to the development of the medicine.
--IANS
bk/tsb/dg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app